Compounds > 3,4-dihydroxybenzohydroxamic acid
Page last updated: 2024-10-26

3,4-dihydroxybenzohydroxamic acid and Glioma

3,4-dihydroxybenzohydroxamic acid has been researched along with Glioma in 2 studies

Glioma: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Figul, M1
Söling, A1
Dong, HJ1
Chou, TC1
Rainov, NG1
Horvath, Z1
Bauer, W1
Hoechtl, T1
Saiko, P1
Fritzer-Szekeres, M1
Tihan, T1
Szekeres, T1

Other Studies

2 other studies available for 3,4-dihydroxybenzohydroxamic acid and Glioma

ArticleYear
Combined effects of temozolomide and the ribonucleotide reductase inhibitors didox and trimidox in malignant brain tumor cells.
    Cancer chemotherapy and pharmacology, 2003, Volume: 52, Issue:1

    Topics: Antineoplastic Agents, Alkylating; Benzamidines; Brain Neoplasms; Dacarbazine; Drug Synergism; Enzym

2003
Combination chemotherapy of BCNU and Didox acts synergystically in 9L glioma cells.
    Nucleosides, nucleotides & nucleic acids, 2004, Volume: 23, Issue:8-9

    Topics: Animals; Anti-Infective Agents, Local; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Ant

2004